AMLAcute my elo ge nou s le u kern i a

ANC Absolute neutrophil count

ANLL Acute non lymphocytic leukemia

CCR C ont i nu ou s cornple t e rem issioii

CD Cluster determinants

CML Chronic myelogenous leukemia

CR Complete remission

CSF Cerebral spinal fluid

DFS Disease-free survival

EFS Eve dl-free survival

FAB French'-Am erica n-British

FISH Fluorescent in-situ hybridizaLion

G-CSF Granu locy le colon y- st i mulat i ng factor

GM-CSF Granulocyte-macrophage cdony-stimulating factor

GVHD Graft-versus-host disease

GVL Graft-versus-leukemia (effect)

HLA Human, leukocyte antigen

HSCT Hematopoietic stem cell transplantation

M DS Myelody spla stic sy od rom e

MPD Myeloproliferative disorder

MRD Minimal residual disease

MUD Matched unrelated donor

ÖS Overall survival

Ph+ Philadelphia chromosome

TBI Total-body radiation

T L S Tu mo r lysis synd rome

WHO World Health Organization

XRT Irradiation

' Self-assessment questions and answers are available at ht-tp://www. mhpharmacotherapy. com/pp.html.

references

1. Pui CH, Relling MV, Downing JR. Acute lymphocytic leukemia. N Engl J Med 2004 Apr; 350(15):1535-1548.

2. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.

3. Campana D, Pui CH. Childhood leukemia. In: Abeloff MD, Armitage JO, Nieder-huber JE, et al., eds. Clinical Oncology, 4th ed. Philadelphia, PA: Elsevier, 2008:2139-2169.

4. Schumacher HR, Alvares CJ, Blough RI, Mazzella F. Acute leukemia. Clin Lab Med 2002;22:153-192.

5. Hoelzer D, Gokbudet N. Acute lymphoid leukemia in adults. In: Abeloff MD, Armitage JO, Niederhuber JE, et al., eds. Clinicol Oncology, 4th ed. Philadelphia, PA: Elsevier, 2008:2191-2213.

6. Leather HL, Bickert B. Acute leukemias. In: DiPiro JT, Talbert RL, Yee GC, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 7th ed. New York City: McGraw-Hill, 2008:2259-2280.

7. Pieters R, Carroll WL. Biology and treatment of acute lymphoblastic leukemia. Pediatr Clin North Am 2008;55(1):1-20.

8. Faderl S, Jeha S, Kantarjian HM. The biology and therapy of adult acute lymphoblastic leukemia. Cancer 2003; 98(7):1337-1354.

9. Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med 1999;341(14):1051-1062.

10. Stone RM, O'Donnell MR, Sekeres MA. Acute myeloid leukemia. Hematology Am Soc Hematol Educ Program 2004;1:98-117.

11. Scheinberg DA, Maslak P, Weiss M. Acute leukemias. In: Devita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2001:2404-2433.

12. Pui CH, Schrappe M, Ribeiro RC, Niemeyer CM. Childhood and adolescent lymphoid and myeloid leukemia. Hematology Am Soc Hematol Educ Program 2004:1;118-145.

13. Pui CH, Relling MV, Campana D, et al. Childhood acute lymphoblastic leukemia. Rev Clin Exp Hematol 2002;6:161-180.

Mandrell BN, Pritchard M. Understanding the clinical implications of minimal residual disease in childhood leukemia. J Pediatr Oncol Nurs 2006;23:38-44.

Carroll WL, Bhojwani D, Min DJ, et al. Pediatric acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2003;1:102-131.

Wells RJ, Arther DC, Srivastava A, et al. Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213. Leukemia 2002; 16:601-607.

Rubnitz JE, Gibson B, Smith FO. Acute myeloid leukemia. Pediatr Clin North Am 2008;55:21-51.

Demark-Wahnefried W, Jones LW. Promoting a healthy lifestyle among cancer survivors. Hematol Oncol Clin North Am 2008;22:319-342.

Pui CH, Campana D, Evans WE. Childhood acute lymphoblastic leukaemia: Current status and future perspectives. Lancet Oncol 2001;2:597-607.

Hurwitz CA. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphocytic leukemia. Cancer 2000;88(8):1964-1969.

Robak T. Acute lymphoblastic leukaemia in elderly patients. Drugs Aging 2004; 21:779-791.

Bailey LC, Lange BJ, et. al. Bone marrow relapse in pediatric acute lymphocytic leukemia. Lancet Oncol 2008;99:873-883.

Pui CH. Acute lymphoblastic leukemia. Pediatr Clin North Am. 1997;44:831-846.

Jeha S. Clofarabine for the treatment of acute lymphoblastic leukemia. Expert Rev Anticancer Ther 2007;7:113-118.

Gregory J, Arceci R. Acute myeloid leukemia in children: A review of risk factors and recent trials. Cancer Invest 2002;20:1027-1037.

Ishii E, Kawasaki H, Isoyama K, Eguchi-Ishimae M, Eguchi M. Recent advances in the treatment of infant acute myeloid leukemia. Leuk Lymphoma 2003;44:741-748.

Lancet JE, Willman CL, Bennett JM. Cancer in the elderly. Hematol Oncol Clin North Am 2000;14:251-267.

Golub TR, Arceci RJ. Acute myelogenous leukemia. In: Pizzo PA, Poplack DG. eds. Principles and Practice of Pediatric Oncology, 5th ed. Philadelphia PA: Lippincott, Williams& Wilkins; 2006: 591-644.

29. Davidson MB, Thakkar S, Hix JK, et al. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med 2004;116:546-554.

30. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-751.

31. Hoelzer D, GokbugetN, Ottmann, et al. Acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2002:162-192.

Anxiety and Depression 101

Anxiety and Depression 101

Everything you ever wanted to know about. We have been discussing depression and anxiety and how different information that is out on the market only seems to target one particular cure for these two common conditions that seem to walk hand in hand.

Get My Free Ebook


Post a comment